Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PMGC Holdings
AddedFeb 18, 2024
UpdatedJul 4, 2026
PMGC Holdings

PMGC Holdings

Seed

Reactive Medical Labs: Pioneering regenerative skincare solutions through advanced biotechnology since 2019.

HQ
San Jose, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Reactive Medical Labs is a biotechnology company focused on developing regenerative skincare applications. Founded in 2019 and based in San Jose, California, the company aims to enhance the penetration of agents across the skin barrier for visible skin conditions. It offers proprietary topical aesthetic and therapeutic prescription-strength skincare systems that isolate pure and potent MSC-derived exosomes.

Reactive Medical Labs has made significant strides in addressing unmet skincare needs, particularly in aging. By leveraging advanced biotechnology, the company has positioned itself as a leader in the regenerative skincare market. Its innovative solutions have garnered attention from healthcare institutions seeking effective treatments for skin aging.

PMGC Holdings - Similar Companies

RegenX Science logo

RegenX Science

regenxscience.com

Repairogen logo

Repairogen

AgeX Therapeutics logo

AgeX Therapeutics

Regenemed logo

Regenemed

regenemed.com

EternoGen logo

EternoGen

Outer Biosciences logo

Outer Biosciences

outerbio.com

Retro Biosciences logo

Retro Biosciences

retro.bio

Biomimetic Laboratories logo

Biomimetic Laboratories

Aesthetics Biomedical logo

Aesthetics Biomedical

Dermamedics logo

Dermamedics

dermamedics.com

OneSkin logo

OneSkin

Altos Labs logo

Altos Labs

altoslabs.com

DermBiont logo

DermBiont

dermbiont.com

AVITA Medical logo

AVITA Medical

avitamedical.com

Forever Labs logo

Forever Labs

foreverlabs.com

PMGC Holdings - Quick Facts

Who are PMGC Holdings' competitors?

Companies similar to PMGC Holdings include RegenX Science, Repairogen, AgeX Therapeutics and Regenemed.

When was PMGC Holdings founded?

PMGC Holdings was founded in 2019.

Where is PMGC Holdings' headquarters located?

PMGC Holdings' headquarters is located in San Jose, CA, US.

When was PMGC Holdings' last funding round?

PMGC Holdings' most recent funding round was for $732.5k (USD) in October 2021.

How much has PMGC Holdings raised to-date?

As of Oct 14, 2021, PMGC Holdings has raised a total of $732.5k (USD).

How many employees does PMGC Holdings have?

PMGC Holdings has 30 employees as of Feb 4, 2024.

PMGC Holdings - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Skincare
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0001840563
  • ticker: ELAB
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research